RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sihuan Pharmaceutical Holdings Group Stock

Sihuan Pharmaceutical Holdings Group Liabilities 2024

Sihuan Pharmaceutical Holdings Group Liabilities

7.1 B CNY

Ticker

460.HK

ISIN

BMG8162K1137

WKN

A1C72G

In 2024, Sihuan Pharmaceutical Holdings Group's total liabilities amounted to 7.1 B CNY, a -4.06% difference from the 7.4 B CNY total liabilities in the previous year.

Sihuan Pharmaceutical Holdings Group Aktienanalyse

What does Sihuan Pharmaceutical Holdings Group do?

Sihuan Pharmaceutical Holdings Group Ltd is a leading company in the Chinese pharmaceutical industry that focuses on research, development, production, and marketing of drugs, especially for the treatment of cardiovascular diseases and central nervous system diseases. The company was founded in 2001 and has become one of the largest and most successful companies in the Chinese pharmaceutical industry. It is listed on the stock exchange and has its headquarters in Beijing, China. Sihuan Pharmaceutical's business model is based on a combined strategy of researching and developing new drugs tailored to the Chinese market, as well as licensing and distributing existing drugs from both domestic and international sources. The company is divided into various business divisions to maximize its core competencies and maintain growth. The cardiovascular division is one of the most important divisions, producing and distributing cardiovascular drugs used to treat conditions such as hypertension, heart failure, arrhythmias, and other cardiovascular diseases. The central nervous system division is another important division, producing and distributing drugs to treat neurological disorders such as depression, schizophrenia, and epilepsy. In addition, the company also has products in the areas of antibiotics, antivirals, and gastroenterology. Sihuan Pharmaceutical's research and development department focuses on the discovery and development of new active substances, as well as improving existing drugs. The company collaborates with leading universities and research institutions in China and globally to develop innovative approaches in pharmacy. Sihuan Pharmaceutical has also established a strong presence in the Chinese market, building an extensive distribution network throughout China and working closely with other key players in the industry to strengthen its market position. In summary, Sihuan Pharmaceutical Holdings Group Ltd is a significant player in the Chinese pharmaceutical industry, specializing in the research, development, production, and marketing of drugs for the treatment of cardiovascular diseases and central nervous system diseases. The company is divided into multiple business divisions and has a strong presence in the Chinese market. With its strong research and development department, Sihuan Pharmaceutical is committed to improving the health and well-being of millions of people worldwide. Sihuan Pharmaceutical Holdings Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Sihuan Pharmaceutical Holdings Group's Liabilities

Sihuan Pharmaceutical Holdings Group's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Sihuan Pharmaceutical Holdings Group's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Sihuan Pharmaceutical Holdings Group's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Sihuan Pharmaceutical Holdings Group's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Sihuan Pharmaceutical Holdings Group’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Sihuan Pharmaceutical Holdings Group stock

What is the level of liabilities of Sihuan Pharmaceutical Holdings Group this year?

Sihuan Pharmaceutical Holdings Group has a debt balance of 7.1 B CNY this year.

What were the liabilities of Sihuan Pharmaceutical Holdings Group compared to the previous year?

The liabilities of Sihuan Pharmaceutical Holdings Group have increased by -4.06% dropped compared to the previous year.

What are the consequences of high debt for investors of Sihuan Pharmaceutical Holdings Group?

High liabilities can pose a risk for investors of Sihuan Pharmaceutical Holdings Group, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Sihuan Pharmaceutical Holdings Group?

Low liabilities mean that Sihuan Pharmaceutical Holdings Group has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Sihuan Pharmaceutical Holdings Group affect the company?

An increase in liabilities of Sihuan Pharmaceutical Holdings Group can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Sihuan Pharmaceutical Holdings Group affect the company?

A decrease in the liabilities of Sihuan Pharmaceutical Holdings Group can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Sihuan Pharmaceutical Holdings Group?

Some factors that can influence the liabilities of Sihuan Pharmaceutical Holdings Group include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Sihuan Pharmaceutical Holdings Group so important for investors?

The liabilities of Sihuan Pharmaceutical Holdings Group are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Sihuan Pharmaceutical Holdings Group take to modify the liabilities?

To change its liabilities, Sihuan Pharmaceutical Holdings Group can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Sihuan Pharmaceutical Holdings Group pay?

Over the past 12 months, Sihuan Pharmaceutical Holdings Group paid a dividend of 0.07 CNY . This corresponds to a dividend yield of about 11.4 %. For the coming 12 months, Sihuan Pharmaceutical Holdings Group is expected to pay a dividend of 0.05 CNY.

What is the dividend yield of Sihuan Pharmaceutical Holdings Group?

The current dividend yield of Sihuan Pharmaceutical Holdings Group is 11.4 %.

When does Sihuan Pharmaceutical Holdings Group pay dividends?

Sihuan Pharmaceutical Holdings Group pays a quarterly dividend. This is distributed in the months of October, July, October, November.

How secure is the dividend of Sihuan Pharmaceutical Holdings Group?

Sihuan Pharmaceutical Holdings Group paid dividends every year for the past 16 years.

What is the dividend of Sihuan Pharmaceutical Holdings Group?

For the upcoming 12 months, dividends amounting to 0.05 CNY are expected. This corresponds to a dividend yield of 8.19 %.

In which sector is Sihuan Pharmaceutical Holdings Group located?

Sihuan Pharmaceutical Holdings Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sihuan Pharmaceutical Holdings Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sihuan Pharmaceutical Holdings Group from 10/10/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Sihuan Pharmaceutical Holdings Group pay the last dividend?

The last dividend was paid out on 10/10/2024.

What was the dividend of Sihuan Pharmaceutical Holdings Group in the year 2023?

In the year 2023, Sihuan Pharmaceutical Holdings Group distributed 0.052 CNY as dividends.

In which currency does Sihuan Pharmaceutical Holdings Group pay out the dividend?

The dividends of Sihuan Pharmaceutical Holdings Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sihuan Pharmaceutical Holdings Group

Our stock analysis for Sihuan Pharmaceutical Holdings Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sihuan Pharmaceutical Holdings Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.